Return On Equity of Sagimet Biosciences Inc. from 31 Dec 2022 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Sagimet Biosciences Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2022 to 30 Sep 2025.
  • Sagimet Biosciences Inc. Return On Equity for the quarter ending 30 Sep 2025 was -42%, a 79% decline year-over-year.
  • Sagimet Biosciences Inc. annual Return On Equity for 2024 was -26%, a 147% decline from 2023.
  • Sagimet Biosciences Inc. annual Return On Equity for 2023 was 55%, a 220% increase from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Sagimet Biosciences Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -42% -19% -79% 01 Jul 2025 30 Sep 2025
Q2 2025 -40% -19% -92% 01 Apr 2025 30 Jun 2025
Q1 2025 -35% +27% +43% 01 Jan 2025 31 Mar 2025
Q4 2024 -26% -81% -147% 01 Oct 2024 31 Dec 2024
Q3 2024 -24% -46% -205% 01 Jul 2024 30 Sep 2024
Q2 2024 -21% -36% -241% 01 Apr 2024 30 Jun 2024
Q1 2024 -62% -77% -500% 01 Jan 2024 31 Mar 2024
Q4 2023 55% +38% +220% 01 Oct 2023 31 Dec 2023
Q3 2023 22% 01 Jul 2023 30 Sep 2023
Q2 2023 15% 01 Apr 2023 30 Jun 2023
Q1 2023 15% 01 Jan 2023 31 Mar 2023
Q4 2022 17% 01 Oct 2022 31 Dec 2022

Sagimet Biosciences Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -26% -81% -147% 01 Jan 2024 31 Dec 2024
2023 55% +38% +220% 01 Jan 2023 31 Dec 2023
2022 17% 01 Jan 2022 31 Dec 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.